111In-pentetreotide scintigraphy in the detection of insulinomas: Importance of SPECT imaging

O. Schillaci, R. Massa, F. Scopinaro

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of this study was to determine whether the systematic use of SPECT can increase the reported low sensitivity of somatostatin receptor scintigraphy (SRS) in detecting insulinomas. Methods: Fourteen patients were evaluated. After 111Inpentetreotide injection (~250 MBq intravenously), abdominal SPECT images were obtained at 4 h and multiple planar images were obtained at 4 and 24 h. MRI and CT were performed within 1 mo of SRS. Sixteen tumors were histologically verified after surgery in 14 patients. Results: SPECT revealed 14 lesions in 12 patients (sensitivity, 87.5%), both planar SRS and MRI revealed 7 tumors in 7 patients (sensitivity, 43.8%), and CT revealed only 5 lesions in 4 patients (sensitivity, 31.3%). Moreover, in 4 patients SPECT was the only examination with positive findings. Conclusion: SPECT at 4 h is mandatory for preoperative detection of insulinomas using SRS because the images are more sensitive than planar images and are superior to images from other conventional methods.

Original languageEnglish
Pages (from-to)459-462
Number of pages4
JournalJournal of Nuclear Medicine
Volume41
Issue number3
Publication statusPublished - 2000

Keywords

  • Insulinomas
  • Somatostatin receptor scintigraphy
  • SPECT

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Fingerprint Dive into the research topics of '<sup>111</sup>In-pentetreotide scintigraphy in the detection of insulinomas: Importance of SPECT imaging'. Together they form a unique fingerprint.

Cite this